Jefferies is maintaining their Buy rating on HealthSpring (NYSE: HS) as the company reported strong 4Q results and released a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE